Dec 15, 2014 02:51 PM EST
German drugmakers including Stada, Torrent's Heumann and Dr. Reddy's betapharm have appealed a regulator's decision to suspend approval of some drugs over concerns about clinical trials conducted by an Indian company.
Regulators in France, Germany, Belgium and Luxembourg this month suspended marketing approval for 25 drugs over the quality of trial data from India's GVK Biosciences.
Companies that have filed an appeal will be allowed to resume sales of affected products until their appeals are either approved or struck down, Germany's Federal Institute for Drugs and Medical Devices (BfArM) said on Monday.
"We are reviewing the appeals thoroughly and quickly," a spokesman for BfArM said.
The regulator last week had published a list of 80 affected products that their manufacturers would not be allowed to sell until they had provided new clinical data.
2. 07:57 AM
Filipino scientists get a thumbs up of their space app from NASA
3. 08:52 AM
New paper provides design principles for disease-sensing nanomaterials
4. Feb 22, 2019
Chemical added to consumer products impairs response to antibiotic treatment
2. Feb 21, 2019
Ingredients for water could be made on surface of moon, a chemical factory
3. Feb 21, 2019
Marine ecosystems changing color influenced by climate change
4. Feb 21, 2019
Innovative nanocoating technology harnesses sunlight to degrade microplastics